Michele Colucci is a venture capital thought leader, lawyer, investor, serial entrepreneur, and philanthropist. She has authored five patents in the technology space and founded companies in the legal, technology, retail, and entertainment spaces. Her extensive experience operating in highly regulated verticals has focused on issues from management to legal. As a venture capitalist focused on med tech, Colucci is committed to impacting the health field by investing in companies that enable doctors to make better diagnostic decisions through the application of AI and big data. She has board of directors experience with public and private firms including Global Indemnity Group, Nephrosant, Optina Diagnostics, Prime Genomics, Prenome, and Trayt. She has been a frequent guest lecturer at Stanford University’s School of Engineering. In 2017, Colucci was named West Coast Ambassador by the Nobel Laureate Foundation. She earned her B.A. and J.D. from Georgetown University and an M.F.A from the AFI. Colucci speaks three languages and currently resides in Silicon Valley with her four children.